Molly Handal

Molly Handal is currently the Director of Business Analytics and Insights for US Oncology at Pfizer, a position they have held since 2021. They previously served as Director of Business Analytics and Insights for US Vaccines at Pfizer since 2018 and were an Associate Director of Market Research at Teva Respiratory from 2011 to 2018. Earlier in their career, Handal worked as a Targeting and Alignment Analyst at Shire Pharmaceuticals and held various roles in market research and analysis at Campbell Alliance and Verispan. Molly earned an MBA from Saint Joseph's University and has a background in business from Saint Joseph's University, where they completed their undergraduate studies.